🚨 We're Exhibiting Today! 🚨
April 24, 2025
Pharmidex is proud to be exhibiting at the 36th BMCS Spring Symposium on Medicinal Chemistry, taking place today at the beautiful Fielder centre in Hatfield! 🏛️✨
We're excited to be part of this key gathering of thought leaders in drug discovery and development, sharing insights, connecting with fellow innovators, and shaping the future of medicinal chemistry.
Our very own
Janette Dalay Robertson
is on-site and would be delighted to meet with attendees. Come say hello!
She’s eager to discuss collaboration opportunities and explore how together we can accelerate breakthroughs in drug discovery and preclinical development.
💬 Let’s connect, innovate, and advance science, one molecule at a time.
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
Pharmidex is proud to offer access to the 8HUM model genetically humanized for 33 liver CYP enzymes responsible for metabolizing 90% of human drugs. ✅ Human-relevant metabolism data ✅ Supports IND-enabling ®gulatory studies ✅ Ideal for metabolite profiling, DDI risk & toxicity assessment By integrating 8HUM into our DMPK and in vivo studies, we deliver deeper, more predictive insights for safer, smarter drug development. 📩 Contact us to see how 8HUM can support your project.
